Silverback Asset Management Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Silverback Asset Management Llc disclosed 10 stock positions valued at approximately $790.66M as of quarter-end June 30, 2026. The largest holdings include HARMONIC INC, CORE SCIENTIFIC INC NEW, and TERAWULF INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 10
- Portfolio Value
- $790.66M
Holdings by Sector
Silverback Asset Management Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| HARMONIC INC | HLIT | Technology | 1.08% | 525,000 | -123,566 | -19.05% | $8,573,250 |
| CORE SCIENTIFIC INC NEW | CORZ | Technology | 0.43% | 131,600 | -29,300 | -18.21% | $3,367,644 |
| TERAWULF INC | WULF | Financial Services | 0.30% | 96,600 | - | - | $2,386,020 |
| AST SPACEMOBILE INC | ASTS | Technology | 0.27% | 24,200 | - | - | $2,150,412 |
| AEROVIRONMENT INC | AVAV | Industrials | 0.25% | 12,100 | - | - | $1,997,347 |
| TEMPUS AI INC | TEM | Healthcare | 0.21% | 28,700 | -7,000 | -19.61% | $1,662,591 |
| EYEPOINT INC | EYPT | Healthcare | 0.09% | 50,000 | - | - | $715,000 |
| MAGNACHIP SEMICONDUCTOR CORP | MX | Technology | 0.06% | 100,000 | -120,000 | -54.55% | $473,000 |
| OCUGEN INC | OCGN | Healthcare | 0.05% | 250,000 | +250,000 | +100.00% | $382,500 |
| ACCURAY INC DEL | ARAY | Healthcare | 0.05% | 1,450,000 | -200,000 | -12.12% | $373,810 |
Showing 10 of 10 holdings in the latest reporting period.
Silverback Asset Management Llc Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | IWM | iShares Russell 2000 ETF | CALL | 275,000 | $82,623,750 |
| Q2 2026 | DFTX | Definium Therapeutics, Inc. | CALL | 294,400 | $13,848,576 |
| Q2 2026 | CYTK | Cytokinetics, Incorporated | CALL | 100,000 | $8,519,000 |
| Q2 2026 | XLV | SPDR Select Sector Fund - Healt | CALL | 50,000 | $7,933,000 |
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | CALL | 50,000 | $7,912,500 |
| Q2 2026 | NTNX | Nutanix, Inc. | CALL | 100,000 | $5,096,000 |
| Q2 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | CALL | 100,000 | $1,430,000 |
| Q2 2026 | PAR | PAR Technology Corporation | CALL | 50,000 | $871,000 |
Showing 8 of 8 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.